Skip to main content

CRISPR halts fatal genetic disease in dogs, could soon do the same in humans

CRISPR gene editing can be used for all manner of applications, from creating more efficient crops or heat-resistant cattle to coding GIFS into DNA. Now, scientists from the University of Texas Southwestern have showcased another potentially transformative use case for the technology: Using CRISPR to halt the progress of Duchenne muscular dystrophy (DMD) in dogs. One day, it could potentially do the same in humans, too.

DMD is the most common fatal genetic disease in children. The result of a mutation that limits the production of muscle-function protein dystrophin, it affects roughly 1 in 3,500 male births worldwide. Children who suffer with DMD often die as a result of their hearts lacking enough strength to pump, or their diaphragm being too weak to breathe. Patients also wind up in wheelchairs as the result of muscular degeneration. No effective treatment currently exists for human patients.

In their demonstration, the UT Southwestern scientists were able to use a single-cut gene-editing technique to restore the dystrophin in muscle and heart tissue by a massive 92 percent. According to experts, a 15 percent threshold could be enough to significantly help patients.

Previously, the researchers showed that it was possible to correct DMD mutations in both mice and human cells. However, in this latest breakthrough, they demonstrated that it is possible to employ this strategy in dogs, by far the largest mammals this has been applied to. Four dogs were involved in the study, all of which shared the same genetic mutation seen in DMD patients. The CRISPR gene-editing components were delivered through a harmless virus, after which it proceeded to carry out the successful gene-editing work.

More work will need to be done before this technique can be carried over to human patients in the form of a clinical trial, but that is the eventual goal. To reach this objective, the UT Southwestern team behind the research — run by regenerative science expert Dr. Eric Olson — has licensed the technology to a biotechnology company called Exonics Therapeutics. Hopefully, it won’t be too long before this work is saving lives around the world.

A paper describing the research was recently published in the journal Science.

Editors' Recommendations

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
New study suggests CRISPR gene editing might have unforeseen side effects
CRISPR gene-editing technology

From the promise of malaria-free mosquitos to a potentially limitless supply of transplant organs or cures for some of humanity’s worst diseases, CRISPR-Cas9 gene editing sounds almost too to be true. Unfortunately, at least according to researchers in the United Kingdom, that could turn out to be true. In a recently published Nature paper, researchers from the Wellcome Sanger Institute -- a nonprofit British genomics and genetics research institute -- warn that gene editing has the potential to end badly. Specifically, they are worried that DNA alterations could result in cells turning cancerous.

Their conclusions are based on studying two genes in different cell types in the form of mouse embryonic stem cells and human immortalized cells. By studying these genes, they observed that genomic damage was a “common outcome.”

Read more
Yale scientists edit genetic diseases out of mice before birth; humans are next
china wireless router pregnant women setting woman

Gene-editing techniques such as CRISPR/Cas9 can be used to astonishing, potential life-altering effect, such as one demonstration involving a possible treatment for ALS. Researchers at Carnegie Mellon University and Yale University have now made a significant breakthrough in the technology’s usefulness -- by demonstrating how gene editing can be used to treat genetic conditions during fetal development.

While so far it has only been showcased in an experiment with mice, in the future it could help treat the millions of children who are born each year with severe genetic disorders or birth defects. At present, some of these genetic conditions can be detected during pregnancy, although they cannot be corrected during fetal development.

Read more
8 Amazing CRISPR projects that could change life as we know it
china crispr human cancer trial gene editing ala cas9

Since it burst onto the scene a decade ago, CRISPR-Cas9 has shaken the field of genetics to its core. Offering a new genomic editing tool that’s faster, cheaper and more accurate than previous approaches, it opens up an astonishing breadth of possible applications.

From saving lives to potentially rescuing coral reefs, here are eight examples of exciting CRISPR projects that showcase just why this gene-editing tech has everyone talking.
Malaria-resistant mosquitos
Gene editing can now change an entire species -- forever | Jennifer Kahn

Read more